Women's views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study)

Marianne Vidler, Laura A. Magee, Peter von Dadelszen, Evelyne Rey, Susan Ross, Elizabeth Asztalos, Kellie E. Murphy, Jennifer Menzies, Johanna Sanchez, Joel Singer, Amiram Gafni, Andrée Gruslin, Michael Helewa, Eileen Hutton, Shoo K. Lee, Terry Lee, Alexander G. Logan, Wessel Ganzevoort, Ross Welch, Jim G. ThorntonJean-Marie Moutquin

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

To compare women's views about blood pressure (BP) control in CHIPS (Control of Hypertension In Pregnancy Study) (NCT01192412). Quantitative and qualitative analysis of questionnaire responses. International randomised trial (94 sites, 15 countries). 911 (92.9%) women randomised to ‘tight’ (target diastolic blood pressure, 85mmHg) or ‘less tight’ (target diastolic blood pressure, 100mmHg) who completed questionnaires. A questionnaire was administered at ∼6–12 weeks postpartum regarding post-discharge morbidity and views about trial participation. Questionnaires were administered by the site co-ordinator, and contact was made by phone, home or clinic visit; rarely, data was collected from medical records. Quantitative analyses were Chi-square or Fisher's exact test for categorical variables, mixed effects multinomial logistic regression to adjust for confounders, and p<0.001 for statistical significance. NVivo software was used for thematic analysis of women's views. Satisfaction, measured as willingness to have the same treatment in another pregnancy or recommend that treatment to a friend. Among the 533 women in ‘tight’ (N=265) vs. ‘less tight’ (N=268) control who provided comments for qualitative analysis, women in ‘tight’ (vs. ‘less tight’) control made fewer positive comments about the amount of medication taken (5 vs. 28 women, respectively) and intensity of BP monitoring (7 vs. 17, respectively). However, this did not translate into less willingness to either have the same treatment in another pregnancy (434, 95.8% vs. 423, 92.4%, respectively; p=0.14) or recommend that treatment to a friend (435, 96.0% and 428, 93.4%, respectively; p=0.17). Importantly, although satisfaction remained high among women with an adverse outcome, those in ‘tight’ control who suffered an adverse outcome (vs. those who did not) were not consistently less satisfied, whereas this was not the case among women in ‘less tight’ control among whom satisfaction was consistently lower for the CHIPS primary outcome (p<0.001), severe hypertension (p≤0.01), and pre-eclampsia (p<0.001). Women in ‘tight’ (vs. ‘less tight’) control were equally satisfied with their care, and more so in the face of adverse perinatal or maternal outcomes.
Original languageEnglish
Pages (from-to)105-113
Number of pages9
JournalEuropean Journal of Obstetrics Gynecology and Reproductive Biology
Volume206
DOIs
Publication statusPublished - 2016

Keywords

  • Hypertension
  • Blood pressure control
  • Pregnancy
  • Postpartum
  • Satisfaction

Fingerprint

Dive into the research topics of 'Women's views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study)'. Together they form a unique fingerprint.

Cite this